| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 13,124 | 11,503 | 11,362 | 11,426 | | Cost of Revenue | 6,754 | 5,967 | 5,711 | 6,148 | | | Gross Profit | 6,370 | 5,536 | 5,651 | 5,278 | | | Operating Expenses | | Research Development | 1,642 | 1,667 | 1,891 | 1,570 | | Selling General and Administrative | 4,411 | 4,343 | 4,111 | 4,391 | | Non Recurring |
-
|
-
|
-
| 33,132 | | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 317 | (474) | (351) | (33,815) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (18) | 61 | 111 | (228) | | Earnings Before Interest And Taxes | 299 | (413) | (240) | (34,043) | | Interest Expense | 54 | 54 | 55 | 55 | | Income Before Tax | 245 | (467) | (295) | (34,098) | | Income Tax Expense | 82 | (390) | (9) | (4,862) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 163 | (77) | (286) | (29,236) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 163 | (77) | (286) | (29,236) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $163 | ($77) | ($286) | ($29,236) |
|
0.03% Nasdaq 0.00%
Income Statement
